# Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling

Source: https://onco.cc/trials/nct00515762/  
OnCo record `nct00515762` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Scalp cooling in Breast cancer, run by Hospital San Carlos, Madrid, completed.

## Summary

Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling is a phase 2 interventional study registered as NCT00515762 by Hospital San Carlos, Madrid, with 150 participants recorded, started 2007-05 and reaching its primary completion in 2010-06. Interventions recorded: elasto-gel cap. Conditions recorded: Alopecia, Breast Cancer.

Linked to the technology Scalp cooling because the registry's title names it ("scalp cooling") and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00515762
- Phase: 2
- Setting: Pilot Trial of Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling (ELASTO-GEL CAPS)in Breast Cancer Patients
- Sponsor: Hospital San Carlos, Madrid
- Enrolled: 150

## Sources

- ClinicalTrials.gov NCT00515762: https://clinicaltrials.gov/study/NCT00515762

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- technologies: [Scalp cooling (cold caps: DigniCap, Paxman)](https://onco.cc/technologies/scalp-cooling/)

---
JSON: https://onco.cc/api/v1/entities/nct00515762.json